Q&A With Retired Neurologist Daniel Gibbs on His Own Alzheimer’s Journey
For the retired neurologist Daniel Gibbs, a diagnosis of early-stage Alzheimer's not only gave him a sense of relief, but also a clear path for his fight against the disease, from living healthy lifestyle and engaging in Alzheimer's advocacy to… More
Aduhelm Side Effects: A Retired Neurologist on His Own Unique Case of ARIA
Following the FDA's approval of the new Alzheimer's drug Aduhelm (aducanumab), retired neurologist Daniel Gibbs spoke with Being Patient in a recent LiveTalk about his own Alzheimer's diagnosis, his unusual and severe case of side effects during aducanumab's clinical trial,… More
Q&A: Dr. Eric Larson on Ways to Lower Dementia Risk—and Why They Work
Lifestyle changes can lower our dementia risk. Dr. Eric Larson, senior investigator at Kaiser Permanente Washington Health Research Institute, dives into the science to help explain just why diet, sleep, physical activity and other factors have such a big impact… More
Q&A: Clinical Trial Investigators Respond to Aduhelm Approval
Following the FDA's approval of aducanumab, marketed under the name Aduhelm, an aducanumab trial principal investigator and a former aducanumab trial site investigator speak with Being Patient about the significance of the decision, controversies surrounding the clinical trials of the… More
“This Is How I’m Living Life:” Perspectives on Dementia
As part of our LiveTalks series, Being Patient spoke with Gail Gregory, Peter Middleton and George Rook about their dementia diagnoses and what it means to live well with the illness. A dementia diagnosis represents a new chapter in life:… More